Skip to main content
. 2016 Mar 6;5(6):1022–1030. doi: 10.1002/cam4.661

Figure 2.

Figure 2

Different phenotypes of isolated circulating tumor cells (iCTCs) and circulating tumor microemboli (CTMs). A1–D1: immunostaining of iCTCs with anti‐PS100 (A1), anti‐TRF2 (B1), anti‐CD10 (C1), and anti‐SOX10 (D1) antibodies (immunoperoxidase, original magnification, ×100). A2–B2: immunostaining of CTMs with anti‐PS100 (A2), anti‐TRF2 (B2), anti‐CD10 (C2), and anti‐SOX10 (D2) antibodies (arrows: stained nuclei; arrowheads, stained cytoplasmic cell membranes; immunoperoxidase, original magnification, ×1000)